Overview

Evaluation of Serum Prostatic Specific Antigen (PSA) After Cyproterone Compound Treatment Compared With Oral Contraceptives Pill in Hirsute Polycystic Ovary Syndrome Patients

Status:
Unknown status

Trial end date:
2010-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the effect of oral contraceptive on the serum free prostatic specific antigen (PSA)in women with polycystic ovary syndrome(PCOD)compared with cyproterone compound.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Shahid Beheshti University

Treatments:

Contraceptive Agents
Contraceptives, Oral
Contraceptives, Oral, Combined
Cyproterone
Cyproterone Acetate